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Sumnman- Microsatellite instabilit; (MSI) was examined at 36 loci. and found in 9 (4300) of the 21 prostatic
cancers. A loss of heterozvgosity had occurred in five cases (24%). MSI did not correlate with clinical stage.
but might plav a role in the development of a subset of prostate cancers.
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Prostate cancer is a common malignancy among elderly men.
However. little is known about the mechanistic involvement
of genetic alterations such as instability. its repair and rep-
lication. In this study. we therefore investigated a series of 21
prostate cancers for microsatellite instability (MSI) and made
a correlation study with clinicopathological factors.
Materials and methods
Tissue samples
The prostates were obtained from 21 patients who visited
Mie University Hospital. Chiba University Hospital or The
Center for Adult Disease between 1991 and 1993. Of the 21
samples. ten were derived from radical prostatectomy and the
remaining 11 were obtained at autopsy. The entire gland was
frozen immediatelv after excision, and sectioned at 0.5 cm
intervals in the transverse plane perpendicular to the rectal
surface. Haematoxylin and eosin-stained sections were prep-
ared from each slice with a cryostat. and subjected to light
microscopic review to assess the suitability for further
analysis and for grading according to the Gleason score
(Gleason and Mellinger. 1974). Only tumours in which
cancer cells represented a significant proportion of the neo-
plastic tissue (more than 75% of the cells) were chosen.
Normal tissue was carefully microdissected from tumorous
portions to provide normal control DNA. All cancers were
staged according to the system of the American Joint Com-
mission on Cancer (Table I).
DNA extraction and anal!sis
Genomic DNA was prepared from frozen samples with pro-
teinase K digestion, serial phenol and chloroform extractions
and ethanol precipitation.
Thirty-six sets of primers were prepared to amplify DNA
fragments (Table II). These primers were first end-labelled
with [y-3P]ATP using T4 polynucleotide kinase (Takara.
Japan). Samples of genomic DNA (50 ng) were amplified by
polvmerase chain reaction (PCR) in a total of 5 jil of reaction
mixture. which consisted of 80 n-m end-labelled primers.
100 lim of each dNTP. 10 mm Tris-HCl (pH 8.3). 50 mM
potassium chloride. 1.5 mm magnesium chloride. 0.001%
gelatin and 0.1 U l1-' Taq DNA polymerase (Perkin Elmer
Cetus. USA). The reaction conditions were 94°C (0.5 mmn).
55'C (0.5 min) and 72°C (1 min) for 40 cycles. The reaction
was initiated with a 3 mmn incubation at 94°C and ended with
7 min at 72'C. Five microlitres of the PCR product was
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added to 45 pl of loading buffer (95% formamide. 20 mM
EDTA. 0.05% bromophenol blue and 0.05% xylene cyanol),
and the entire sample was denatured at 90°C for 2 min and
placed on ice. Aliquots (1 tl) of samples were loaded into
lanes of 6% polyacrylamide gels. Gels were dried and
autoradiographed after electrophoresis.
For all examined prostate cancers. a comparison of the
electrophoretic mobility of nucleotide repeats from paired
normal and cancerous tissue DNA was performed. In addi-
tion. abnormal shifts in electrophoretic mobility were
confirmed by repeated experiments.
Results
A total of 21 prostate cancers were examined for MSI at 36
microsatellite loci. Nine prostate cancers (43%) showed MSI.
multiple in three cases. involving a total of nine microsatellite
loci (Table III). The remaining six tumours revealed MSI at
one locus. The most frequent locus with MSI was TP53,
occurring in three cases (3, 4 and 11). Two cases showed MSI
at the 16S312 locus. The ratios of cases with MSI for each
stage were 100% (3 3) for stage A. 25% (1 4) for stage B,
50% (2 4) for stage C and 30% (3 10) for stage D. There was
no relationship between MSI and clinicopathological factors
such as the Gleason score. stage and age of the patients.
Figure la shows differences in DNA banding patterns
Table I Clinicopathological features of the 21 prostate cancers
Gleason
Case Age Stage Score
1 76 A 4
2, 78 A 8
3 45 A 9
4 82 B 7
5 66 B 5
6 65 B 6
7 57 B 8
8 73 C 6
9 64 C 5
10 61 C 6
11 67 C 8
12 67 D 5
13 77 D 7
14 75 D 9
15 75 D 9
16 42 D 9
17 66 D 9
18 80 D 9
19 83 D 9
20 83 D 9
21 75 D 10
Average 69.3 7.48between cancerous and corresponding normal tissue for
D2S97, D3S1211 and TP53 loci, indicating size alterations in
cancerous tissue. Sequencing of the DNA from case 2 at the
D3S1211 locus showed that the tumour tissue contained
(CA)24, whereas the normal sample contained (CA)19 repeats.
In contrast, case 17 showed contraction of nucleotide repeats
at D16S312.
We simultaneously analysed loss of heterozygosity (LOH)
of microsatellite alleles during the examination of micro-
satellite markers. Five samples (24%) showed LOH, of which
three (2, 8 and 13) also exhibited MSI. LOH at chromosome
16 was the most common (cases 2, 12 and 13), followed by
chromosome 8 (cases 2 and 6). There was no relationship
between the presence of LOH and clinicopathological factors.
Figure lb illustrates LOH of case 2 for D8S205 and sample
cases 2 and 12 for D16S313. For D16S313, the loss of one
allele in case 12 was seen with additional contraction of the
other allele.
Table II The examined microsatellite repeats
Marker Chromosome Repeat
DIS161I 1 (CA),'
D2S933 2 (GT)16
D2S95a 2 (GT)17
D2S97a 2 (GT)15
D3S1211 3 (CA)15
D4S244a 4 (CA)18
D5S352u 5 (GT,1
D6S225a 6 (CA)18
D7S461a 7 (CA)20
D8S205a 8 (GT)1g
D8S206a 8 (GT)16
D8S207a 8 (GT)20
D8S2083 8 (CA)20
D9S58b 9 (GT)28
D9S131a 9 (GT)17
D1OS172a 10 (G1}=
D1OS173a 10 (CA)19
D10S174a 10 (CA)20
DlOS175a 10 (CA),,
D1I S862a 11 (CA)16
D12S72a 12 (GT)n
D13S1 15a 13 (CA)19
D14S57a 14 (GT)17
D1 5S98a 15 (CA)20
D15S104a 15 (CA)18
D16S310a 16 (ATAG)12
D16S312a 16 (CA)23
D16S313a 16 (CA)20
D17S5813 17 (CA)16
D17S583a 17 (CA)14
D18S36Z 18 (GT)2
D19S198a 19 (CA)18
D20S75a 20 (CA)17
D21S222a 21 (CA),1
ADRc X (CAG)25
TP53d 17 (CA)25
aHudson et al. (1992). 6Kwiatkowski et al. (1992). cYamamoto et al.
(1992). dJones and Nakamura (1992).
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In the present study, we found MSI in 9 (43%) of 21 primary
prostate cancers using 36 microsatellite markers. After the
first reports of widespread alterations in simple repeated
DNA sequences in familial colorectal cancers (Aaltonen et
al., 1993; Thibodeau et al., 1993), such changes have been
reported in various human cancers. The reported frequencies
in colorectal cancers have ranged from 11.6% to 28% (Aal-
tonen et al., 1993; Lothe et al., 1993; Peltomaki et al., 1993;
Thibodeau et al., 1993), and that in gastric cancers from
22.7% to 39% (Han et al., 1993; Mironov et al., 1994). In
urogenital cancers, published data are 25% in renal cell
carcinomas (Uchida et al., 1994), 23% in endometrial car-
cinomas (Burks et al., 1994) and 3% in bladder cancers
(Gonzalez-Zulueta et al., 1993). The frequency of MSI in
prostate cancer, at 43%, is as high as that in small-cell lung
cancer (45%; Merlo et al., 1994) but lower than that in
multiple primary cancers (89%; Horii et al., 1994), in which
MSI is associated with a poor prognosis. Recently, a high
frequency (65%) has been reported (Gao et al., 1994) for a
series of 57 prostate cancers examined for 18 microsatellite
loci on 12 chromosomes. According to this report 40% of the
patients studied demonstrated MSI at chromosome 6p, and
more than 20% showed it at 8p. 13q, 16q, 17p and/or 18q.
Though overall frequency is high in this study, the ratio of
a
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Figure I (a) Examples of MSI in primary prostate cancers. N.
normal DNA obtained from non-cancerous tissues. T. tumour
DNA from the same patient. The microsatellite markers are
shown above each panel. Case 8 demonstrated MSI (extraction
bands) for D2S97, and case 2 for D3S1211, case 17 for D16S312,
and case 11 for TP53. (b) LOH revealed at D8S205 (case 2) and
D16S313 (cases 2. 15 and 13).
Table III Results ofmicrosatellite instability and LOH in human prostate cancer
Sample no.
1 2 3 4 6 8 11 12 13 15 17
2S97 - - - - - + - -
3S1211 - + - - - L - - - - +
8S205 - L - - - - - - + - -
8S206 - - - - L - - - + - -
10S172 - + - - - - - - - - -
10S173 - + - - - - - - - - -
15S104 - L - - - - - - - - -
16S312 - + - - - - - L - - +
16S313 - L - - - - - - L - -
17S581 + - - - - - - - - + -
TP53 - - + + - - + - - - -
+ . microsatellite instability detected;-. microsatellite instability not detected; L loss
of heterozygosity.MC rolib instability in procie cancer
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MSI in each locus is not high. The highest frequency is 14%
(3 21). found at TP53. and the second highest is less than 5%
(2 21) at three loci. Gao et al. (1994) found a positive corr-
elation between MSI and invasive high-grade cancers, which
contrasts with our results. Differences in the nucleotides
repeat types and the number of examined loci may explain
the discrepancy. Alternatively, it may be due to geographic
differences. because genetic alterations in prostatic car-
cinomas are known to differ among different populations
(Watanabe et al.. 1994a).
The androgen receptor gene contains CAG repeats. Some
patients with X-linked spinal and bulbar muscular atrophy
have androgen dysfunction and amplified CAG repeats
(Yamamoto et al.. 1992). However. no alteration of this
microsatellite locus was found in this study. All the stage D
cancers analysed occurred after hormonal therapy and were
androgen independent. Thus. androgen independency in pro-
state cancer may not be directly associated with MSI, though
other portions of the androgen receptor gene were not
analysed.
LOH of microsatellite alleles. especially of chromosomes 8
and 16 was observed relatively frequently in this study. Our
findings are in line with previous chromosome studies show-
ing such loss on chromosomes 8. 10 and 16 (Bergerheim et
al., 1991). and demonstrate that LOH can be found. along
with MSI. even in early-stage prostate cancers. Frequent
LOH has been reported in small-ell lung cancers, which are
associated with MSI (Merlo et al., 1994). but an inverse
correlation between MSI and LOH in colorectal and breast
cancers has been descnbed (Thibodeau et al.. 1993: Yee et
al., 1994). Although the precise mechanisms underlying LOH
are unknown, LOH and MSI may coexist at an early stage in
carcinogenesis of the prostate glands and be involved in a
different manner from that in breast and colorectal cancers.
We previously examined the samples analysed in this study
for p53 gene mutations (Watanabe et al., 1994b), and found
two (cases 13 and 17) to have p53 gene mutations on each in
exons 2 and 5. Case 13 showed MSI at 8S205 and 206, case
17 at 3S1212 and 16S312. Neither case had MSI at TP53.
While the coexistence of allelic loss and a mutation in the
other allele of the p53 gene has been found to be common in
colorectal cancer (Kikuchi-Yanoshita et al., 1992). it was not
observed in our senes.
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